Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials

Autor:	Silverberg, Jonathan I, Wollenberg, Andreas, Reich, Adam, Thaçi, Diamant, Legat, Franz J, Papp, Kim A, Stein Gold, Linda, Bouaziz, Jean-David, Pink, Andrew E, Carrascosa, José Manuel, Rewerska, Barbara, Szepietowski, Jacek C, Krasowska, Dorota, Havlíčková, Blanka, Kalowska, Monika, Magnolo, Nina, Pauser, Sylvia, Nami, Navid, Sauder, Maxwell B, Jain, Vipul, Padlewska, Kamila, Cheong, Soo Yeon, Fleuranceau Morel, Patricia, Ulianov, Liliana, Piketty, Christophe *
Zdroj:	In The Lancet 3-9 August 2024 404(10451):445-460
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu